Breaking News
August 21, 2018 - Researchers create the world’s first artificial retina
August 21, 2018 - Yale researchers identify racial disparities in prescribing opioids for chronic pain
August 21, 2018 - BOOST-3 clinical trial aims to improve outcomes for severe TBI patients
August 21, 2018 - New study highlights Alzheimer’s herpes link, experts say
August 21, 2018 - Airline crew don’t have significantly elevated risk of thyroid cancer, new study finds
August 21, 2018 - States leverage federal funds to help insurers lower premiums
August 21, 2018 - New badge course explores research around skeletal muscle as an endocrine organ
August 21, 2018 - TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
August 21, 2018 - Increased levels of human herpesvirus ID’d in Alzheimer’s
August 21, 2018 - To help patients quash pain, researcher develops practical guide for health care providers
August 20, 2018 - Medicine on the front line to be presented at Medical Innovation 2018
August 20, 2018 - Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody
August 20, 2018 - The man who sold America on vitamin D — and profited in the process
August 20, 2018 - Finding the light in antimicrobials
August 20, 2018 - Unique pain program helps surgical patients wean off opioids safely and effectively
August 20, 2018 - Strawberries could mitigate colonic inflammation
August 20, 2018 - FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters
August 20, 2018 - Using Facebook to help young adults quit smoking
August 20, 2018 - ‘Liquid biopsy’ predicts lymphoma therapy success within days | News Center
August 20, 2018 - 5 Questions with Jordan Orange, Chair of Pediatrics
August 20, 2018 - New assay may help improve both sarcoma diagnosis and treatment
August 20, 2018 - New information on the brain regions related to metacognition, tactile sense
August 20, 2018 - New class of insect repellents to fight against mosquito-borne diseases
August 20, 2018 - ACA Coverage Gains Include Workers Without Insurance
August 20, 2018 - 3-D printed biomaterials for bone tissue engineering
August 20, 2018 - Current surveillance system does not quickly pick up most listeriosis cases in the EU, study reveals
August 20, 2018 - Prenatal exposure to acute stress can affect cognitive function in children of low-income households
August 20, 2018 - New study examines scope of state policies targeting drug use by pregnant women
August 20, 2018 - Researchers find long-term structural, functional brain abnormalities in individuals with AUDs
August 20, 2018 - Shortage of insurance fraud cops sparks campaign debate
August 20, 2018 - Researchers find STAT3 as therapeutic target for chronic active EBV infection
August 20, 2018 - Health Tip: Keep Diabetic Feet Healthier
August 20, 2018 - FDA approves brain stimulation device for OCD
August 20, 2018 - NYU Langone’s Perlmutter Cancer Center expands Blood and Marrow Transplant Program
August 20, 2018 - New drug shows potential to prevent painful side effect of therapy
August 20, 2018 - RDMD raises $3 million in seed funding to accelerate rare disease research, drug development
August 20, 2018 - Illicit drug use is higher during celebratory events, may be worse than previously thought
August 20, 2018 - Exploring the relationship between fever and cancer incidence
August 20, 2018 - Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival
August 20, 2018 - Brain tumors trap immune cells needed to fight cancer in the bone marrow, finds research
August 20, 2018 - Three factors that contribute to physician burnout
August 20, 2018 - Babies dependent on opioids need touch, not tech
August 20, 2018 - Understanding How Antibodies Shape the Gut Microbiome
August 20, 2018 - Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of Korsuva (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus
August 20, 2018 - Kidney transplant chains more effective in saving lives
August 20, 2018 - Study unravels cellular and molecular mechanisms behind dermal condensate formation
August 20, 2018 - New integrated gene logic-chips could have great value in medical care
August 20, 2018 - FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
August 20, 2018 - Total, open repairs decline for abdominal aortic aneurysms
August 20, 2018 - Novel system can pinpoint ingestible implants inside the body using wireless signals
August 20, 2018 - Infection rates of high risk oral HPV in England found to be lower than expected
August 20, 2018 - Making robots as valuable and trustworthy assistants for medical therapies
August 20, 2018 - Patients with low-risk blood clots can be better treated at home than at hospital
August 20, 2018 - Passive smoking exposure among kids greatly increases COPD risk late in life
August 20, 2018 - Primary Care Provider Burnout Rate Low in Small Practices
August 20, 2018 - Discovery presents treatment hope for Alzheimer’s and other neurodegenerative diseases
August 20, 2018 - Stroke patients appear to receive better care at teaching hospitals with less chance of readmission
August 20, 2018 - Distinct origin of ADHD identified In children with history of traumatic brain injury
August 20, 2018 - AHA: Wildfire Smoke Threatens Health of Those Near and Far
August 20, 2018 - Here’s a mental health workout that’s as simple as ABC
August 20, 2018 - Newly discovered cytoskeleton utilized by cancer cells for survival
August 19, 2018 - Bifidobacteria supplement colonizes gut of breastfed infants
August 19, 2018 - Why patients with Alzheimer’s markers never develop the condition
August 19, 2018 - ACA’s Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment
August 19, 2018 - Important factor may be missing in models used to predict spread of epidemics from climate change
August 19, 2018 - Indian-Americans have fewer sudden infant deaths, study finds
August 19, 2018 - Experts advise against universal genomic screening of newborns
August 19, 2018 - New trial to investigate whether weight loss before conception can make mom and baby healthier
August 19, 2018 - Sun Pharma Announces FDA Approval of Cequa (cyclosporine) Ophthalmic Solution to Treat Dry Eye Disease
August 19, 2018 - Researchers examining Parkinson’s resilience
August 19, 2018 - HPI, INTEGRIS and USPI enter into agreement to offer patients more choice, flexibility of care
August 19, 2018 - Researchers find mechanism that prepares brain to replicate repeated actions
August 19, 2018 - Those who are emotionally stable when young may remain the most stable as they age
August 19, 2018 - URI professor develops simpler and quicker method for detecting impurity in heparin
August 19, 2018 - Mayo Medical Laboratories and NDSC collaborate to develop new patient blood-management solution
August 19, 2018 - Insight into endocrine cancers and treatment options
August 19, 2018 - HPV Legislation Doesn’t Impact Teen Sexual Behaviors
August 19, 2018 - Exenatide treatment alleviated symptoms of depression in patients
August 19, 2018 - Tufts researchers win grant to study integration of genomic sequencing into neonatal care
August 19, 2018 - Novel finger-prick test can help prevent toxoplasmosis
Lung Disease Common in Late-Onset SLE

Lung Disease Common in Late-Onset SLE

image_pdfDownload PDFimage_print

Action Points

  • Patients with late-onset systemic lupus erythematosus (SLE) are more likely to develop pulmonary manifestations of the disease than are patients with early-onset disease, according to a meta-analysis of 39 studies.
  • Recognize that most patients with SLE begin to develop the disease early in life, only a minority become symptomatic after age 50, and previous studies have suggested that there are differences in clinical manifestations between late- and early-onset SLE.

Patients with late-onset systemic lupus erythematosus (SLE) are more likely to develop pulmonary manifestations of the disease than are patients with early-onset disease, a meta-analysis demonstrated.

Among patients whose SLE was diagnosed after age 50, the odds ratio for having interstitial lung disease was 2.56 (95% CI 1.27-5.16, I2=26%), according to Christie M. Bartels, MD, and colleagues from the University of Wisconsin in Madison.

Increased risks also were seen for patients with late-onset SLE for pleuritis (OR 1.53, 95% CI 1.19-1.96, I2=36%) and serositis (OR 1.31, 95% CI 1.05-1.65, I2=61%), the researchers reported online in Seminars in Arthritis & Rheumatism.

Most patients with SLE begin to develop the disease early in life, but a minority only become symptomatic after age 50. Previous studies have suggested that there are differences in clinical manifestations between late- and early-onset systemic lupus erythematosus, including fewer cutaneous manifestations such as malar rash and photosensitivity in the older group.

Lung manifestations in general are common in SLE, with pleuritis being seen in up to half of patients and interstitial lung disease in up to 13%.

One recent study found more pulmonary manifestations in patients with adult-onset disease compared with childhood-onset, but patients older than 50 were not included.

Pulmonary fibrosis in general becomes more common with increasing age, but it has not been established whether patients with late-onset lupus are more susceptible to lung manifestations.

Therefore, Bartels and colleagues conducted a systematic literature review and meta-analysis of cohort and case-control studies on pulmonary involvement in late- and early-onset SLE published through 2016.

They identified 39 studies, 35 of which were cohort studies and the remaining four being case-control studies. Heterogeneity was assessed with the I2 statistic; 25%, 50%, and 75% represented low, moderate, and high heterogeneity between studies, respectively.

The studies included 10,963 patients with early-onset lupus and 1,656 patients with late-onset disease. The cohorts included were geographically and ethnically diverse, and the mean quality score of the individual studies was 6.3 out of 9.

The number of patients with late-onset SLE in the studies ranged from seven to 131.

Although there were trends toward significance, the risks were not statistically significant in the older-onset group for pulmonary embolism (OR 2.73, 95% CI 0.78-9.60, I2=0%) and pulmonary hypertension (OR 1.72, 95% CI 0.22-13.49, I2=0%), but with significantly increased for a combined category of “any” pulmonary manifestation (OR 1.70, 95% CI 1.36-2.14, I2=60%).

When case-control studies were excluded from the analysis, the risks remained elevated in the older onset group for interstitial lung disease (RR 2.21, 95% CI 1.14-4.31) and pleuritis (RR 1.39, 95% CI 1.12-1.73).

Many potential factors may contribute to the increased pulmonary risks among late-onset lupus patients, including effects on both the innate and adaptive immune systems. For example, neutrophils in older individuals are less capable of killing phagocytosed pathogens but have increased apoptosis, and thymic production of naive T-cells declines, leading to proliferation of memory T cells and a resulting proinflammatory state.

An additional contributory factor for interstitial lung disease in older patients may be a possible SLE-Sjogren’s syndrome overlap syndrome, which has been reported by several groups. The prevalence of interstitial lung disease in Sjogren’s syndrome, at 9% to 75%, is much higher than in SLE, at 1% to 15%, so an overlap syndrome could explain the high incidence in older patients.

“In addition to a possible Sjogren’s overlap phenotype in late-onset SLE, factors such as duration of disease, environmental exposures, and smoking trends over time might also correlate with SLE interstitial lung disease,” the researchers observed.

“Clinicians should recognize that late-onset patients are more likely to have interstitial lung disease and screen for the condition when appropriate,” they concluded.

Strengths of the analysis included the large, multinational cohort and the high quality of the studies included.

Limitations included inconsistent methods of pulmonary diagnosis in the various studies and the possibility of misclassification of serositis.

The authors have received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health and the Independent Grants for Learning and Change (Pfizer).


Tagged with:

About author

Related Articles